L
Luis Miguel Gutiérrez-Robledo
Researcher at National Institutes of Health
Publications - 120
Citations - 5611
Luis Miguel Gutiérrez-Robledo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 30, co-authored 111 publications receiving 4333 citations. Previous affiliations of Luis Miguel Gutiérrez-Robledo include San Antonio River Authority.
Papers
More filters
Journal ArticleDOI
Searching for an Operational Definition of Frailty: A Delphi Method Based Consensus Statement. The Frailty Operative Definition-Consensus Conference Project
Leocadio Rodríguez-Mañas,Catherine Féart,Catherine Féart,Giovanni E. Mann,Jose Viña,Somnath Chatterji,Wojtek Chodzko-Zajko,Magali Gonzalez-Colaço Harmand,Howard Bergman,Laure Carcaillon,Caroline Nicholson,Angelo Scuteri,Alan J. Sinclair,Martha Peláez,Tischa J. M. van der Cammen,François Béland,Jerome Bickenbach,Paul Delamarche,Luigi Ferrucci,Linda P. Fried,Luis Miguel Gutiérrez-Robledo,Kenneth Rockwood,Fernando Rodríguez Artalejo,Gaetano Serviddio,Enrique Vega +24 more
TL;DR: There is agreement on the usefulness of defining frailty in clinical settings as well as on its main dimensions, however, additional research is needed before an operative definition of frailty can be established.
Journal ArticleDOI
Cognitive Impairment Improves the Predictive Validity of the Phenotype of Frailty for Adverse Health Outcomes: The Three-City Study
José Alberto Avila-Funes,Hélène Amieva,Pascale Barberger-Gateau,Mélanie Le Goff,Nadine Raoux,Karen Ritchie,Isabelle Carrière,Béatrice Tavernier,Christophe Tzourio,Luis Miguel Gutiérrez-Robledo,Jean-François Dartigues +10 more
TL;DR: To determine whether adding cognitive impairment to frailty improves its predictive validity for adverse health outcomes, a study of memory loss in elderly people with dementia is conducted.
Journal ArticleDOI
Frailty: An Emerging Public Health Priority
Matteo Cesari,Martin Prince,Jotheeswaran Amuthavalli Thiyagarajan,Islene Araujo de Carvalho,Roberto Bernabei,Piu Chan,Luis Miguel Gutiérrez-Robledo,Jean-Pierre Michel,John E. Morley,Paul Ong,Leocadio Rodríguez Mañas,Alan J. Sinclair,Chang Won Won,John R. Beard,Bruno Vellas +14 more
TL;DR: The identification of frailty as a target for implementing preventive interventions against age-related conditions is pivotal and every effort should be made by health care authorities to maximize efforts in this field.
Journal ArticleDOI
Frailty Among Community-Dwelling Elderly People in France: The Three-City Study
José Alberto Avila-Funes,Catherine Helmer,Hélène Amieva,Pascale Barberger-Gateau,Mélanie Le Goff,Karen Ritchie,Florence Portet,Isabelle Carrière,Béatrice Tavernier,Luis Miguel Gutiérrez-Robledo,Jean-François Dartigues +10 more
TL;DR: The construct proposed by Fried and colleagues confirms its predictive validity for adverse-health outcomes, particularly for certain components of disability, thus suggesting that it may be useful in population screening and predicting service needs.
Journal ArticleDOI
International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
Mikel Izquierdo,Mikel Izquierdo,Mikel Izquierdo,Reshma A. Merchant,John E. Morley,Stefan D. Anker,Ivan Aprahamian,Hidenori Arai,Mylène Aubertin-Leheudre,Roberto Bernabei,Eduardo Lusa Cadore,M. Cesari,Lizhu Chen,P. de Souto Barreto,Gustavo Duque,Luigi Ferrucci,Roger A. Fielding,Antonio García-Hermoso,Antonio García-Hermoso,Luis Miguel Gutiérrez-Robledo,Stephen D. R. Harridge,Ben Kirk,S. B. Kritchevsky,Francesco Landi,Norman R. Lazarus,Finbarr C. Martin,Emanuele Marzetti,Marco Pahor,Robinson Ramírez-Vélez,Robinson Ramírez-Vélez,Leocadio Rodríguez-Mañas,Yves Rolland,Jorge G. Ruiz,Olga Theou,Dennis T. Villareal,Debra L. Waters,C. Won Won,Jean Woo,Bruno Vellas,M. Fiatarone Singh +39 more
TL;DR: In this paper, the authors provide evidence-based rationale for using exercise and physical activity (PA) for health promotion and disease prevention and treatment in older adults, and discuss the specific modalities and doses that have been studied in randomised controlled trials for their effectiveness in attenuating physiological changes of ageing, disease prevention, and/or improvement of older adults with chronic disease and disability.